These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 25897340)

  • 1. Coating Solid Lipid Nanoparticles with Hyaluronic Acid Enhances Antitumor Activity against Melanoma Stem-like Cells.
    Shen H; Shi S; Zhang Z; Gong T; Sun X
    Theranostics; 2015; 5(7):755-71. PubMed ID: 25897340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD44 targeted chemotherapy for co-eradication of breast cancer stem cells and cancer cells using polymeric nanoparticles of salinomycin and paclitaxel.
    Muntimadugu E; Kumar R; Saladi S; Rafeeqi TA; Khan W
    Colloids Surf B Biointerfaces; 2016 Jul; 143():532-546. PubMed ID: 27045981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovarian cancer targeted hyaluronic acid-based nanoparticle system for paclitaxel delivery to overcome drug resistance.
    Wang L; Jia E
    Drug Deliv; 2016 Jun; 23(5):1810-7. PubMed ID: 26530693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyaluronic acid-shelled acid-activatable paclitaxel prodrug micelles effectively target and treat CD44-overexpressing human breast tumor xenografts in vivo.
    Zhong Y; Goltsche K; Cheng L; Xie F; Meng F; Deng C; Zhong Z; Haag R
    Biomaterials; 2016 Apr; 84():250-261. PubMed ID: 26851390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paclitaxel-loaded redox-sensitive nanoparticles based on hyaluronic acid-vitamin E succinate conjugates for improved lung cancer treatment.
    Song Y; Cai H; Yin T; Huo M; Ma P; Zhou J; Lai W
    Int J Nanomedicine; 2018; 13():1585-1600. PubMed ID: 29588586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual drugs (microRNA-34a and paclitaxel)-loaded functional solid lipid nanoparticles for synergistic cancer cell suppression.
    Shi S; Han L; Deng L; Zhang Y; Shen H; Gong T; Zhang Z; Sun X
    J Control Release; 2014 Nov; 194():228-37. PubMed ID: 25220161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cluster of Differentiation 44 Targeted Hyaluronic Acid Based Nanoparticles for MDR1 siRNA Delivery to Overcome Drug Resistance in Ovarian Cancer.
    Yang X; Iyer AK; Singh A; Milane L; Choy E; Hornicek FJ; Amiji MM; Duan Z
    Pharm Res; 2015 Jun; 32(6):2097-109. PubMed ID: 25515492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic active targeting of dually integrin αvβ3/CD44-targeted nanoparticles to B16F10 tumors located at different sites of mouse bodies.
    Shi S; Zhou M; Li X; Hu M; Li C; Li M; Sheng F; Li Z; Wu G; Luo M; Cui H; Li Z; Fu R; Xiang M; Xu J; Zhang Q; Lu L
    J Control Release; 2016 Aug; 235():1-13. PubMed ID: 27235150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose paclitaxel via hyaluronan-functionalized bovine serum albumin nanoparticulate assembly for metastatic melanoma treatment.
    Chen X; Wang M; Hu Y; Gong T; Zhang ZR; Yu R; Fu Y
    J Mater Chem B; 2020 Mar; 8(10):2139-2147. PubMed ID: 32090232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyaluronic acid-coated nanostructured lipid carriers for targeting paclitaxel to cancer.
    Yang XY; Li YX; Li M; Zhang L; Feng LX; Zhang N
    Cancer Lett; 2013 Jul; 334(2):338-45. PubMed ID: 22776563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyaluronic acid hydrogels with defined crosslink density for the efficient enrichment of breast cancer stem cells.
    Tan S; Yamashita A; Gao SJ; Kurisawa M
    Acta Biomater; 2019 Aug; 94():320-329. PubMed ID: 31125725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved anti-tumor activity and safety profile of a paclitaxel-loaded glycyrrhetinic acid-graft-hyaluronic acid conjugate as a synergistically targeted drug delivery system.
    Zhang L; Zhou JP; Yao J
    Chin J Nat Med; 2015 Dec; 13(12):915-24. PubMed ID: 26721710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folate and CD44 receptors dual-targeting hydrophobized hyaluronic acid paclitaxel-loaded polymeric micelles for overcoming multidrug resistance and improving tumor distribution.
    Liu Y; Sun J; Lian H; Cao W; Wang Y; He Z
    J Pharm Sci; 2014 May; 103(5):1538-47. PubMed ID: 24619562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific cancer stem cell-therapy by albumin nanoparticles functionalized with CD44-mediated targeting.
    Li Y; Shi S; Ming Y; Wang L; Li C; Luo M; Li Z; Li B; Chen J
    J Nanobiotechnology; 2018 Dec; 16(1):99. PubMed ID: 30501644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual targeting folate-conjugated hyaluronic acid polymeric micelles for paclitaxel delivery.
    Liu Y; Sun J; Cao W; Yang J; Lian H; Li X; Sun Y; Wang Y; Wang S; He Z
    Int J Pharm; 2011 Dec; 421(1):160-9. PubMed ID: 21945183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor targeting profiling of hyaluronan-coated lipid based-nanoparticles.
    Mizrahy S; Goldsmith M; Leviatan-Ben-Arye S; Kisin-Finfer E; Redy O; Srinivasan S; Shabat D; Godin B; Peer D
    Nanoscale; 2014 Apr; 6(7):3742-52. PubMed ID: 24569711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyaluronic acid decorated pluronic P85 solid lipid nanoparticles as a potential carrier to overcome multidrug resistance in cervical and breast cancer.
    Wang F; Li L; Liu B; Chen Z; Li C
    Biomed Pharmacother; 2017 Feb; 86():595-604. PubMed ID: 28027535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyaluronic acid-modified selenium nanoparticles for enhancing the therapeutic efficacy of paclitaxel in lung cancer therapy.
    Zou J; Su S; Chen Z; Liang F; Zeng Y; Cen W; Zhang X; Xia Y; Huang D
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3456-3464. PubMed ID: 31469318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenografts.
    Zhong Y; Zhang J; Cheng R; Deng C; Meng F; Xie F; Zhong Z
    J Control Release; 2015 May; 205():144-54. PubMed ID: 25596560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of a chemopreventive agent and paclitaxel in CD44-targeted hybrid nanoparticles for breast cancer treatment.
    Tran BN; Nguyen HT; Kim JO; Yong CS; Nguyen CN
    Arch Pharm Res; 2017 Dec; 40(12):1420-1432. PubMed ID: 29027133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.